Calcitonin as an anticalcification treatment for implantable biological tissues - PubMed (original) (raw)
. 2019 Feb;73(2):179-182.
doi: 10.1016/j.jjcc.2018.07.010. Epub 2018 Oct 28.
Affiliations
- PMID: 30377016
- DOI: 10.1016/j.jjcc.2018.07.010
Free article
Calcitonin as an anticalcification treatment for implantable biological tissues
E Andreas Agathos et al. J Cardiol. 2019 Feb.
Free article
Abstract
Background and aim of the study: Calcification remains the major role of failure of implantable biomedical material and in particular of bioprosthetic valves. Various treatments have been proposed to mitigate calcification of glutaraldehyde-fixed bioprosthetic valves but none have succeeded in inhibiting or mitigating efficiently the calcification process of the implantable biological tissues. Since the discovery of calcitonin (CT) and its therapeutic role in treating hypercalcemic patients, CT has never been tried as an anticalcification treatment for biomaterials. It is postulated, that tissue calcification may be efficiently minimized by forming adducts with aldehyde groups thus eliminating the places of the biological tissues onto the calcium cations could be deposited.
Material and methods: Fresh porcine aortic leaflets were cut radially in three parts. Three groups of tissue were created. Group I (glutaraldehyde only), Group II (glutaraldehyde with 1% CT) and Group III (glutaraldehyde with 10% CT). All tissues were then implanted subdermally in three sets of 8 (Group I) and 9 (Group II and Group III) male Wistar rats of 12 days old. 21 days later the rats were euthanized by inhalation of CO2. The tissues were retrieved and after rinsing with distilled water 3 times, were lyophilized at -40°C at high vacuum pressure of approximately 100mmHg for 16h. The calcium content was then measured with flat atomic absorption technique.
Results: The preimplantation values of Ca concentration as expressed in mg Ca/g of tissue were 1.79±0.14 in Group I, 4.78±0.0079 in Group II and 2.88±0.17 in Group III (p=ns). 21 days later the values of Ca concentration were 126.95±12.97 for Group I, 24.69±2.71 for Group II (p<0.05) and 27.16±2.95 for Group III (p<0.05). There was not significance difference between Groups II and III, even if Group II showed a less accumulation of Ca concentration (×5.16) than Group III (×9.43).
Conclusion: An anticalcification treatment based on calcitonin as an additive to buffered glutaraldehyde, mitigates the calcification process of the implantable biological tissues, as compared to glutaraldehyde treatment only.
Keywords: Anticalcification treatment; Bioprosthetic valves; Calcitonin.
Copyright © 2018 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Similar articles
- A novel anticalcification treatment strategy for bioprosthetic valves and review of the literature.
Agathos EA, Tomos PI, Kostomitsopoulos N, Koutsoukos PG. Agathos EA, et al. J Card Surg. 2019 Oct;34(10):895-900. doi: 10.1111/jocs.14151. Epub 2019 Jul 3. J Card Surg. 2019. PMID: 31269321 Review. - Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships.
Vyavahare NR, Hirsch D, Lerner E, Baskin JZ, Zand R, Schoen FJ, Levy RJ. Vyavahare NR, et al. J Biomed Mater Res. 1998 Jun 15;40(4):577-85. doi: 10.1002/(sici)1097-4636(19980615)40:4<577::aid-jbm9>3.0.co;2-c. J Biomed Mater Res. 1998. PMID: 9599034 - Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.
Park CS, Kim YJ, Lee JR, Lim HG, Chang JE, Jeong S, Kwon N. Park CS, et al. Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):391-399. doi: 10.1093/icvts/ivx131. Interact Cardiovasc Thorac Surg. 2017. PMID: 28505294 - AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model.
Webb CL, Schoen FJ, Levy RJ. Webb CL, et al. ASAIO Trans. 1988 Jul-Sep;34(3):855-9. ASAIO Trans. 1988. PMID: 3143392 - Calcification of tissue heart valve substitutes: progress toward understanding and prevention.
Schoen FJ, Levy RJ. Schoen FJ, et al. Ann Thorac Surg. 2005 Mar;79(3):1072-80. doi: 10.1016/j.athoracsur.2004.06.033. Ann Thorac Surg. 2005. PMID: 15734452 Review.
Cited by
- Electrospun bioresorbable polymer membranes for coronary artery stents.
Rezvova MA, Ovcharenko EA, Klyshnikov KY, Glushkova TV, Kostyunin AE, Shishkova DK, Matveeva VG, Velikanova EA, Shabaev AR, Kudryavtseva YA. Rezvova MA, et al. Front Bioeng Biotechnol. 2024 Aug 21;12:1440181. doi: 10.3389/fbioe.2024.1440181. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39234270 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous